AbAMPdb: a database of Acinetobacter baumannii specific antimicrobial peptides
Database · 12.10.2024 · 2024
DOI: 10.1093/database/baae096 ↗Kurz gefasst
Fachartikel in der Zeitschrift Database, online erschienen am 12.10.2024. Verfasst von Farha Anwer und 13 weiteren Autor:innen. Beteiligte Einrichtung: Atta-ur-Rahman School of Applied Biosciences (ASAB), National University of Sciences and Technology (NUST), Sector H-12, Islamabad 44000, Pakistan. Hauptthemen laut MEDLINE: Acinetobacter baumannii, Databases, Protein, Antimicrobial Peptides. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Higher Education Commission (HEC), Pakistan, under the National Research Program for Universities (NRPU) project.
Abstract (Originalsprache)
Acinetobacter baumannii has emerged as a prominent nosocomial pathogen, exhibiting a progressive rise in resistance to therapeutic interventions. This rise in resistance calls for alternative strategies. Here, we propose an alternative yet specialized resource on antimicrobial peptides (AMPs) against A. baumannii. Database ‘AbAMPdb’ is the manually curated collection of 300 entries containing the 250 experimental AMP sequences and 50 corresponding synthetic or mutated AMP sequences. The mutated sequences were modified with reported amino acid substitutions intended for decreasing the toxicity and increasing the antimicrobial potency. AbAMPdb also provides 3D models of all 300 AMPs, comprising 250 natural and 50 synthetic or mutated AMPs. Moreover, the database offers docked complexes comprising 5000 AMPs and their corresponding A. baumannii target proteins. These complexes, accessible in Protein Data Bank format, enable the 2D visualization of the interacting amino acid residues. We are confident that this comprehensive resource furnishes vital information concerning AMPs, encompassing their docking interactions with virulence factors and antibiotic resistance proteins of A. baumannii. To enhance clinical relevance, the characterized AMPs could undergo further investigation both in vitro and in vivo. Database URL: https://abampdb.mgbio.tech/
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Atta-ur-Rahman School of Applied Biosciences (ASAB), National University of Sciences and Technology (NUST), Sector H-12, Islamabad 44000, Pakistan.
- School of Interdisciplinary Engineering & Sciences (SINES), National University of Sciences and Technology (NUST), Sector H-12, Islamabad 44000, Pakistan.
- Department of Medical Lab Technology, BIC, University of Harīpur, Haripur, Khyber Pakhtunkhwa 22620, Pakistan.
- Xylexa Inc, National University of Sciences and Technology (NUST), Sector H-12, Islamabad 44000, Pakistan.
- MGBIO (SMC-PRIVATE) Limited, C4 H Building 1, National Science and Technology Park, NUST, H-12, Islamabad 44000, Pakistan.
ORCID-Profile: Farha Anwer
Förderung
- Higher Education Commission (HEC), Pakistan, under the National Research Program for Universities (NRPU) project
Zitieren
APA
Anwer, F., Navid, A., Faiz, F., Haider, U., Nasir, S., Farooq, M., Zahra, M., Bano, A., Bashir, H. H., Ahmad, M., Abbas, S. A., Room, S. E., Saeed, M. T., & Ali, A. (2024). AbAMPdb: a database of Acinetobacter baumannii specific antimicrobial peptides. Database, 2024. https://doi.org/10.1093/database/baae096
Vancouver
Anwer F, Navid A, Faiz F, Haider U, Nasir S, Farooq M, et al. AbAMPdb: a database of Acinetobacter baumannii specific antimicrobial peptides. Database. 2024;2024. doi:10.1093/database/baae096
BibTeX
@article{Anwer2024,
author = {Anwer, Farha and Navid, Ahmad and Faiz, Fiza and Haider, Uzair and Nasir, Samavi and Farooq, Muhammad and Zahra, Maryam and Bano, Anosh and Bashir, Hafiza Hira and Ahmad, Madiha and Abbas, Syeda Aleena and Room, Shah E and Saeed, Muhammad Tariq and Ali, Amjad},
title = {AbAMPdb: a database of Acinetobacter baumannii specific antimicrobial peptides},
journal = {Database},
year = {2024},
volume = {2024},
doi = {10.1093/database/baae096}
}
EUVIMED